medigraphic.com
ISSN 2448-8909 (Print)

2024, Number 1

<< Back Next >>

Med Crit 2024; 38 (1)

ST-segment elevation myocardial infarction in a patient with SARS-CoV-2 (COVID-19) disease

Ortiz NB, Romero LA, Pérez SAH, Reyes JAE, Rico ACV

Language: Spanish
References: 9
Page: 61-65
PDF size: 239.61 Kb.


ABSTRACT

Objective: describe the presence of myocardial infarction in a patient with SARS-CoV-2 disease. Presentation of case: case report of a 72-year-old male with COVID-19 disease, who was admitted to the intensive care unit in April 2020 undergoing fibrinolysis therapy with tecnecteplase, complicating his chronic kidney disease exacerbation that required renal support therapy with peritoneal dialysis. With clinical improvement in cardiac function, renal and respiratory function, discharging to the outpatient clinic. Conclusions: this case clearly illustrates how the COVID-19 pandemic can influence STEMI care and outcomes. Fortunately, even though only fibrinolysis was offered, the patient had a satisfactory evolution. However, protocols should be established for the management of patients with COVID-19 positive STEMI in order to reduce the times to start treatment.


REFERENCES

  1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi: 10.1056/NEJMoa2002032.

  2. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.

  3. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:108427. doi: 10.1016/j.clim.2020.108427.

  4. Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, et al. Cardiovascular implications of the COVID-19 pandemic: a global perspective. Can J Cardiol. 2020;36(7):1068-1080. doi: 10.1016/j.cjca.2020.05.018.

  5. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.

  6. Kunal S, Sharma SM, Sharma SK, Gautam D, Bhatia H, Mahla H, et al. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart J. 2020;72(6):593-598. doi: 10.1016/j.ihj.2020.10.005.

  7. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382(25):e102. doi: 10.1056/NEJMoa2007621.

  8. Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631.

  9. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020;46(6):1111-1113. doi: 10.1007/s00134-020-05993-9.




2020     |     www.medigraphic.com